Carregant...
Familial Hypercholesterolemia and Lipoprotein Apheresis
Lipoprotein apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH) to remove low-density lipoprotein (LDL), which is the main pathogenic factor. Currently, three procedures are available in Japan, including the plasma exchange, double-membrane filtration, and...
Guardat en:
| Publicat a: | J Atheroscler Thromb |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Japan Atherosclerosis Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6711846/ https://ncbi.nlm.nih.gov/pubmed/31231083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17033 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|